Literature DB >> 2293241

Potassium channel openers and vascular smooth muscle relaxation.

G Edwards1, A H Weston.   

Abstract

Potassium channel openers comprise a diverse group of chemical agents which open plasma-lemmal K-channels. They show selectivity for smooth muscle, although K-channels in cardiac and skeletal muscle, neurones and the pancreatic beta-cell are also affected at relatively high concentrations. In addition, at least one endogenous K-channel opener of vascular origin--endothelium-derived hyperpolarizing factor--exists and in man plays a role in modulating blood vessel tone. The type of K-channel involved in the actions of both exogenous and endogenous K-channel openers is still uncertain, although a prime candidate in smooth muscle seems similar to the [ATPi]-modulated K-channel in the pancreatic beta-cell. This review focuses attention on the action of these agents in vascular smooth muscle and on the possible clinical exploitation of their powerful vasorelaxant properties.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293241     DOI: 10.1016/0163-7258(90)90082-d

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  22 in total

Review 1.  Potassium channel openers. Pharmacological effects and future uses.

Authors:  S Duty; A H Weston
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Cyclosporin A does not possess K+ channel opening properties in smooth muscle.

Authors:  B D Edwards; F W Ballardie; M Miller; A H Weston
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 3.  Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?

Authors:  P Pickkers; M Schachter; A D Hughes; M D Feher; P S Sever
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

4.  Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo.

Authors:  S J Downing; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.

Authors:  P J Bijlstra; J A Lutterman; F G Russel; T Thien; P Smits
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

6.  Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

Authors:  M D Randall; H Ujiie; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle.

Authors:  H C Parkington; M A Tonta; H A Coleman; M Tare
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

8.  Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.

Authors:  A I McCulloch; M D Randall
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  Ca(2+)-dependent K+ channels of high conductance in smooth muscle cells isolated from rat cerebral arteries.

Authors:  Y Wang; D A Mathers
Journal:  J Physiol       Date:  1993-03       Impact factor: 5.182

10.  Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.

Authors:  M D Randall; T M Griffith
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.